In a subgroup of high-risk Asians, telmisartan was non-inferior to ramipril and better tolerated in the prevention of cardiovascular events.

PLoS One · 2010 · PMC3006195 · PMID 21200437

Europe PMC DOI

hedged sentences

0.0820

closest p · 1.6× alpha

0.0820

boldest claim

The sentences

did not reach statistical significancep = 0.082so close (0.05 < p ≤ 0.1)

Absolute rates of the composite outcome were generally the same, with slightly less events among Asians on telmisartan (HR = 0.87; 95% CI:0.74,1.02), but this did not reach statistical significance (p = 0.082).

also in 75,278 other papers

an interesting trendno p-value reported

Both measures showed an interesting trend, that Asians were generally more tolerant, even when they were on placebo.

also in 1,024 other papers

of borderline significanceno p-value reported

Results showed that the effect of telmisartan on the primary outcome was of borderline significance, probably because of an unexpectedly lower number of outcome events [5] .

also in 1,677 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.